ArticleKidney international reports2022

Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR:

David Z I Cherney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.